共 100 条
[1]
Boyd CM(2005)Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance JAMA 294 716-724
[2]
Darer J(2005)Polypharmacy in elderly patients Am J Geriatr Pharmacother. 5 345-351
[3]
Boult C(2015)Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines BMJ 350 1-8
[4]
Fried LP(2003)The risk of adverse reaction in elderly patients undergoing polypharmacy Jpn J Pharm Health Care Sci. 29 100-106
[5]
Boult L(2004)A systematic literature review of factors affecting outcome in older medical patients admitted to hospital Age Ageing 33 110-115
[6]
Wu AW(2006)Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study J Gerontol A Biol Sci Med Sci 61 170-175
[7]
Hajjar ER(2005)The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998–2001 Arch Intern Med 165 2069-2076
[8]
Cafiero AC(2010)Potentially inappropriate prescribing and cost outcomes for older people: a national population study Br J Clin Pharmacol 69 543-552
[9]
Hanlon JT(2017)Study on risk of polypharmacy caused by diabetes Jap J Pharm Diabetes. 6 179-187
[10]
Dumbreck S(2005)Guided prescription of psychotropic medications for geriatric inpatients Arch Intern Med 165 802-807